IMMIX BIOPHARMA, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $-4.7M | $391.1K |
| FY2021 | — | $18.0M | $17.6M |
| FY2022 | — | $13.2M | $13.4M |
| FY2023 | — | $16.4M | $17.5M |
| FY2024 | — | $13.3M | $17.7M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $-4.7M | $391.1K |
| FY2021 | — | $18.0M | $17.6M |
| FY2022 | — | $13.2M | $13.4M |
| FY2023 | — | $16.4M | $17.5M |
| FY2024 | — | $13.3M | $17.7M |